--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
CVKD Cadrenal Therapeutics
- 16.170
- +1.680+11.59%
Close Dec 20 16:00 ET
- 15.520
- -0.650-4.02%
Post 18:03 ET
26.82MMarket Cap-2.62P/E (TTM)
18.000High15.326Low202.02KVolume15.890Open14.490Pre Close3.39MTurnover18.47%Turnover RatioLossP/E (Static)1.66MShares32.55052wk High7.86P/B17.69MFloat Cap5.40052wk Low--Dividend TTM1.09MShs Float101.250Historical High--Div YieldTTM18.46%Amplitude5.400Historical Low16.757Avg Price1Lot Size
Cadrenal Therapeutics Key Stats
Cadrenal Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Cadrenal Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
